Chugai Pharmabody

Global Chugai News Release

Thursday, 18 April 2019 6:00 AM

Nemolizumab Shows Positive Results in Maruho’s Phase 3 Study in Atopic Dermatitis

Wednesday, 17 April 2019 5:00 AM

F. Hoffmann-La Roche Announces First Quarter Sales 2019

Monday, 8 April 2019 7:30 AM

Conclusion of Exclusive Licensing and Capital Tie-up Agreements Concerning “Telomelysin (OBP-301),” Oncolytic Viral Immunotherapy